Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Head & Neck 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Pancreatic Neoplasms 4Breast Neoplasms 4Sarcoma 3Melanoma 3Gastrointestinal Stromal Tumors 3Colorectal Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Liver Neoplasms 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Kidney Neoplasms 1Hypertension 1Glioblastoma 1Gallbladder Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Hepatocellular 1Advanced Gastric Cancer 1

Interventions

Specimen Handling 6X-Rays 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Carboplatin 5Paclitaxel 4Nuclear Medicine Department, Hospital 4Biopsy 4selpercatinib 3Thiotepa 3Melphalan 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3Filgrastim 3Etoposide 3Busulfan 3tazemetostat 2sargramostim 2olaparib 2larotrectinib 2etoposide phosphate 2erdafitinib 2ensartinib 2Vemurafenib 2Temozolomide 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Mesna 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × pazopanib × Gastrointestinal × Clear all
NCT01639911 2019-07-22

Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

University of Illinois at Chicago

Phase 1 Completed
28 enrolled
BreastCNSDermatologicGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Melanoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡